Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENCANTO: N-TEC vs Standard of Care for Patellofemoral Osteoarthritis
NCT06576583Phase 2Recruiting
- Sponsor
- University Hospital Basel
- Start
- Jul 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of rimegepant in patellofemoral osteoarthritis, sponsored by University Hospital Basel. Started Jul 2025; status: recruiting.
02
Drugs
rimegepant
03
Conditions
patellofemoral osteoarthritis
Beyond the preview
Go deeper on NCT06576583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06576583.